Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Hourfar

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
International Journal of Laboratory Hematology|August 5, 2008
Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening?M K Hourfar, L A Walch, G Geusendam, et al.
Vox Sanguinis|April 27, 2011
Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in GermanyW Sireis, B Rüster, C Daiss, et al.
Vox Sanguinis|December 21, 2012
Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufactureM M Müller, M I G Fraile, M K Hourfar, et al.
Vox Sanguinis|September 22, 2011
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009W K Roth, M P Busch, A Schuller, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
International Journal of Laboratory Hematology|August 5, 2008
Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening?M K Hourfar, L A Walch, G Geusendam, et al.
Vox Sanguinis|April 27, 2011
Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in GermanyW Sireis, B Rüster, C Daiss, et al.
Vox Sanguinis|December 21, 2012
Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufactureM M Müller, M I G Fraile, M K Hourfar, et al.
Vox Sanguinis|September 22, 2011
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009W K Roth, M P Busch, A Schuller, et al.
Pageof 2